Saurabh Saha

CIK: 0001861926

Transaction Breakdown

Open Market Buys (P)1 (2.4%)

High conviction signal

Open Market Sales (S)23 (56.1%)

Position reduction

Option Exercises (M)9 (22.0%)

Derivative conversions

Awards (A)3 (7.3%)

Compensation grants

Other (G, F, J, C, D, …)5 (12.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CLVT

CLARIVATE PLC

Director

CNTA

Centessa Pharmaceuticals plc

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (41 total)

CLVT
CLARIVATE PLC
May 14, 2026
Award(A)
Direct
62.3K shares-
CLVT
CLARIVATE PLC
May 13, 2026
Tax Payment(F)
Direct
8.2K shares at avg. $2.44$20K
CNTA
Centessa Pharmaceuticals plc
Jul 21, 2025
Exercise(M)
Direct
55K shares at avg. $3.85$212K
CNTA
Centessa Pharmaceuticals plc
Jul 21, 2025
Sale(S)
Direct
55K shares at avg. $15.92$876K
CNTA
Centessa Pharmaceuticals plc
Jun 20, 2025
Exercise(M)
Direct
55K shares at avg. $3.85$212K
CNTA
Centessa Pharmaceuticals plc
Jun 20, 2025
Sale(S)
Direct
55K shares at avg. $12.63$695K
CNTA
Centessa Pharmaceuticals plc
May 20, 2025
Exercise(M)
Direct
55K shares at avg. $3.85$212K
CNTA
Centessa Pharmaceuticals plc
May 20, 2025
Sale(S)
Direct
55K shares at avg. $12.71$699K
CLVT
CLARIVATE PLC
May 7, 2025
Award(A)
Direct
39.5K shares-
CLVT
CLARIVATE PLC
May 6, 2025
Tax Payment(F)
Direct
5K shares at avg. $4.17$21K
CNTA
Centessa Pharmaceuticals plc
Apr 22, 2025
Sale(S)
Direct
40.3K shares at avg. $12.43$501K
CNTA
Centessa Pharmaceuticals plc
Apr 21, 2025
Sale(S)
Direct
14.7K shares at avg. $12.29$180K
CNTA
Centessa Pharmaceuticals plc
Mar 20, 2025
Sale(S)
Direct
55K shares at avg. $16.69$918K
CLVT
CLARIVATE PLC
Mar 3, 2025
Purchase(P)
Direct
58.3K shares at avg. $4.36$254K
CNTA
Centessa Pharmaceuticals plc
Feb 20, 2025
Sale(S)
Direct
54.2K shares at avg. $15.92$863K
CNTA
Centessa Pharmaceuticals plc
Feb 20, 2025
Sale(S)
Direct
775 shares at avg. $16.54$13K
CNTA
Centessa Pharmaceuticals plc
Feb 3, 2025
Award(A)
Share Option (right to buy)
Direct
900K shares-
CNTA
Centessa Pharmaceuticals plc
Feb 1, 2025
Tax Payment(F)
Direct
43.4K shares at avg. $16.92$734K
CNTA
Centessa Pharmaceuticals plc
Jan 21, 2025
Sale(S)
Direct
53.4K shares at avg. $15.76$841K
CNTA
Centessa Pharmaceuticals plc
Jan 21, 2025
Sale(S)
Direct
1.6K shares at avg. $16.19$26K
CNTA
Centessa Pharmaceuticals plc
Dec 31, 2024
Tax Payment(F)
Direct
36.3K shares at avg. $16.35$593K
CNTA
Centessa Pharmaceuticals plc
Dec 20, 2024
Sale(S)
Direct
55K shares at avg. $17.44$959K
CNTA
Centessa Pharmaceuticals plc
Dec 6, 2024
Sale(S)
Direct
87.5K shares at avg. $18.46$1.6M
CNTA
Centessa Pharmaceuticals plc
Dec 6, 2024
Exercise(M)
Direct
87.5K shares at avg. $5.84$511K
CNTA
Centessa Pharmaceuticals plc
Nov 25, 2024
Sale(S)
Direct
299 shares at avg. $18.23$5K

		Type	Shares	Price		Ownership
May 14, 2026	CLVT CLARIVATE PLC	Award(A)	62,264	-	$0	Direct
May 13, 2026	CLVT CLARIVATE PLC	Tax Payment(F)	8,178	$2.44	$19,954	Direct
Jul 21, 2025	CNTA Centessa Pharmaceuticals plc	Exercise(M)	55,000	$3.85	$211,750	Direct
Jul 21, 2025	CNTA Centessa Pharmaceuticals plc	Sale(S)	55,000	$15.92	$875,600	Direct
Jun 20, 2025	CNTA Centessa Pharmaceuticals plc	Exercise(M)	55,000	$3.85	$211,750	Direct
Jun 20, 2025	CNTA Centessa Pharmaceuticals plc	Sale(S)	55,000	$12.63	$694,826	Direct
May 20, 2025	CNTA Centessa Pharmaceuticals plc	Exercise(M)	55,000	$3.85	$211,750	Direct
May 20, 2025	CNTA Centessa Pharmaceuticals plc	Sale(S)	55,000	$12.71	$699,111	Direct
May 7, 2025	CLVT CLARIVATE PLC	Award(A)	39,473	-	-	Direct
May 6, 2025	CLVT CLARIVATE PLC	Tax Payment(F)	4,974	$4.17	$20,742	Direct
Apr 22, 2025	CNTA Centessa Pharmaceuticals plc	Sale(S)	40,344	$12.43	$501,476	Direct
Apr 21, 2025	CNTA Centessa Pharmaceuticals plc	Sale(S)	14,656	$12.29	$180,100	Direct
Mar 20, 2025	CNTA Centessa Pharmaceuticals plc	Sale(S)	55,000	$16.69	$918,060	Direct
Mar 3, 2025	CLVT CLARIVATE PLC	Purchase(P)	58,275	$4.36	$254,079	Direct
Feb 20, 2025	CNTA Centessa Pharmaceuticals plc	Sale(S)	54,225	$15.92	$863,267	Direct
Feb 20, 2025	CNTA Centessa Pharmaceuticals plc	Sale(S)	775	$16.54	$12,821	Direct
Feb 3, 2025	CNTA Centessa Pharmaceuticals plc	Award(A) Share Option (right to buy)	900,000	-	-	Direct
Feb 1, 2025	CNTA Centessa Pharmaceuticals plc	Tax Payment(F)	43,381	$16.92	$734,007	Direct
Jan 21, 2025	CNTA Centessa Pharmaceuticals plc	Sale(S)	53,375	$15.76	$841,115	Direct
Jan 21, 2025	CNTA Centessa Pharmaceuticals plc	Sale(S)	1,625	$16.19	$26,315	Direct
Dec 31, 2024	CNTA Centessa Pharmaceuticals plc	Tax Payment(F)	36,263	$16.35	$592,900	Direct
Dec 20, 2024	CNTA Centessa Pharmaceuticals plc	Sale(S)	55,000	$17.44	$959,057	Direct
Dec 6, 2024	CNTA Centessa Pharmaceuticals plc	Sale(S)	87,496	$18.46	$1,615,255	Direct
Dec 6, 2024	CNTA Centessa Pharmaceuticals plc	Exercise(M)	87,496	$5.84	$510,977	Direct
Nov 25, 2024	CNTA Centessa Pharmaceuticals plc	Sale(S)	299	$18.23	$5,451	Direct

1-25 of 41 transactions

About SAHA SAURABH

SAHA SAURABH (SEC CIK 0001861926) files insider reports with the SEC as Director of CLARIVATE PLC (CLVT) and Chief Executive Officer of Centessa Pharmaceuticals plc (CNTA).

Signal8 holds 22 ownership filings by SAHA SAURABH, all Form 4s, filed between Sep 4, 2024 and May 15, 2026. Those filings report 41 transactions, from Aug 30, 2024 to May 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on SAHA SAURABH's filings is in CHESHIRE, X0.

Recent filings by SAHA SAURABH

May 14, 2026: Grant or award of CLVT shares (Form 4, code A).
May 13, 2026: Tax withholding of CLVT shares (Form 4, code F).
Jul 21, 2025: Option exercise of CNTA shares (Form 4, code M).
Jul 21, 2025: Open-market sale of CNTA shares (Form 4, code S).
Jun 20, 2025: Option exercise of CNTA shares (Form 4, code M).

Other insiders filing for CLARIVATE PLC (CLVT)

Levy Henry, President, LS&H
Cornick Kenneth L., Director
Bomba Jane L Okun, Director
Snyder Andrew Miles, Director
Lisowski Matthew J., Senior VP, CAO
Easton Michael M, Executive Vice President/CFO

How to read Form 4 transaction codes